Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03084367 · ClinicalTrials.gov registry record
Physiologic Assessment of Coronary Stenosis Following PCI
A clinical trial, sponsored by Volcano Corporation.
- Completed
- Registry status
- 500
- Enrollment target
NCT03084367 is a clinical trial that has completed, run by Volcano Corporation. The registered enrollment target is 500 participants.
The verdict
NCT03084367 has completed, sponsored by Volcano Corporation.
- COMPLETED
- Registry status
- 500 participants
- Enrollment target
Study Summary
This is a pilot study designed to assess the relationship between iFR (instantaneous wave-free ratio) pullback and the distribution of coronary atheroma/stenoses as assessed by Quantitative Coronary Angiography (QCA) post angiographically successful PCI (Percutaneous Coronary Intervention).
Interventions
- DIAGNOSTIC_TEST iFR pullback
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2017-06-20 |
| Est. Completion | 2020-02-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03084367
The ClinicalTrials.gov registry entry for NCT03084367 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Volcano Corporation, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which iFR pullback is the first listed.
NCT03084367 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03084367 about?
NCT03084367 is a clinical study titled "Physiologic Assessment of Coronary Stenosis Following PCI". This is a pilot study designed to assess the relationship between iFR (instantaneous wave-free ratio) pullback and the distribution of coronary atheroma/stenoses as assessed by Quantitative Coronary Angiography (QCA) post angiographically successful PCI (Percutaneous Coronary Intervention).
What is the current status of trial NCT03084367?
This trial is currently completed. The enrollment target is 500 participants. The study started on 2017-06-20. Estimated completion is 2020-02-18.
What interventions are being tested in trial NCT03084367?
The interventions under investigation include: iFR pullback (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03084367?
This trial is sponsored by Volcano Corporation, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.